Objective: Asymptomatic pyuria (ASP) is associated with a higher risk of complicated urinary tract infections among diabetic patients. We investigated the association between glycemic status and ASP in an adult population undergoing a health checkup in Hualien, east-central Taiwan.
Introduction
Diabetic patients have an increased risk of symptomatic urinary tract infections (UTIs) and UTI complications (e.g., bacteremia, renal abscesses, and renal papillary necrosis), especially among women. 1e4 It has been suggested that asymptomatic bacteriuria (ASB) is a major risk factor of developing symptomatic UTIs and subsequent renal dysfunction. 5, 6, 7 Several reports have shown that people with diabetes have a higher prevalence of ASB compared with those without diabetes, especially among women. 8e11 ASB has been shown to be a predictor for hospitalization with a UTI in diabetic adults. 12 Some investigators have even suggested that ASB is a complication of diabetes in women. 13 However, data are conflicting as to whether people with diabetes do have a higher prevalence of ASB. 14e16 Furthermore, most of the research has been conducted among women in Western countries, and mostly in clinic-or hospital-based populations. There is evidence suggesting that the association between diabetes and ASB may differ among different ethnic groups. For example, a study in an Asian population failed to show a higher prevalence of ASB in diabetic women. 16 In addition, data are limited regarding the proposed association in men. 4 To our knowledge, there are no reports on whether ASB is more prevalent among people with diabetes in Taiwan, either male or female. To further investigate these issues, we conducted this research in a population of Taiwanese people undergoing a health checkup that included adult men and women to assess the relationship between diabetes and ASB. Urine culture and urinary leukocyte counts (pyuria) are both suitable diagnostic tests for ASB. 10, 17 We used pyuria as a surrogate for bacteriuria in this study.
Materials and methods

Study group
The study group comprised participants who had a health checkup sponsored by the National Health Insurance in our hospital between June 1, 2001 and September 1, 2006. The NHI-sponsored health checkup program is a nationwide project that offers a periodic free comprehensive health exam to beneficiaries aged 40 years and older. The free health checkup service is offered annually to people aged 65 years and older, but every 3 years to those aged 40e64 years. Some participants had more than one health checkup in this hospital during the study period, but we analyzed only data from the first health checkup.
Definition of pyuria and glycemic disorders
There were 9229 participants in the study. A case-control analysis was conducted. Cases (n ¼ 979) were patients who had pyuria, which was defined as the presence of more than 10 leukocytes per high-power field in the urinalysis. Controls (n ¼ 8250) comprised the other patients who had no pyuria. As a health checkup population, these patients were assumed to be asymptomatic. Their glycemic status was classified as normal [with a fasting blood glucose (FBG) of <100 mg/dL and no history of diabetes], prediabetic (with a FBG of 100e125 mg/dL and no history of diabetes), or diabetic (with a FBG of >125 mg/dL or with a history of diabetes).
Data collection
After a fasting period of at least 8 hours, a complete blood count, fasting blood sugar, renal function, liver function, uric acid, lipid profile, and sediment urinalysis were conducted in participants. They then completed questionnaires regarding their medical history (diabetes, hypertension, and hyperlipidemia), smoking, alcohol consumption, betel nut chewing, demographic factors, and family history of major cardiovascular diseases. A physician then carried out a physical examination of the participants. Data on their blood tests were automatically entered into an electronic database, while data from the questionnaires were manually entered into the same database. Participants were enrolled in this study if they had complete data on their glycemic status (a history of diabetes and FBG) and urinalysis. We used the database to explore the relationship between glycemic status and asymptomatic pyuria (ASP). The potential confounding factors considered were age, sex, body mass index (BMI), smoking, alcohol consumption, betel nut chewing, a history of hypertension or hyperlipidemia, hyperuricemia (serum uric acid >7.2 mg/dL), liver dysfunction (glutamate pyruvate transaminases >42 mg/dL), and nephropathy (serum creatinine >1.5 mg/dL). BMI and age were considered as continuous variables, while all others were treated as categorical variables. This study was approved by the institutional review committee of the hospital.
Statistical analysis
Logistic regression was used to analyze the relation between glycemic status and ASP while adjusting for other potential confounding factors, including age, sex, history of hypertension, smoking, alcohol consumption and nephropathy. Other factors were tested for their effects on the odds ratio (OR) estimate and were not included in the model, since they did not change the OR estimate for diabetes by 10% or more. We first examined whether the glycemic status of the cases and controls differed, as well as other potential confounding factors. Because sex was found to have different effects on the glycemiaeASP association, we then assessed the glycemiaeASP association stratified by sex. The ORs were calculated with 2005 Stata statistical software (Intercooled Stata 8.2; Stata Corporation, College Station, TX, USA).
Results
The prevalence of ASP was 10.6% [95% confidence interval (CI): 9.9e11.2%] in this population, with 15.9% (95% CI: 14.9e16.9%) for women and 4.7% (95% CI: 4.1e5.3%) for men. The prevalences of ASP in adults with glycemic statuses classified as diabetic, prediabetic, and normal were 23.4%, 18.0%, and 13.4% in women, and 5.6%, 4.2%, and 4.6% in men, respectively. Of the 9229 participants, 1572 had a diabetic, 2024 had a prediabetic, and 5633 had a normal glycemic status. Table 1 shows the characteristics of the cases and controls. The two groups had no differences in terms of BMI, betel nut chewing, hypertensive status, hyperuricemia, or liver dysfunction. The cases were more likely to be older, female, dyslipidemic, and nephropathic, but they were less likely to be smokers or drink alcohol. The prevalence of prediabetes and/or diabetes tended to be higher in the cases than in controls.
The effects of glycemic status on ASP appeared to differ among women versus men (p for interaction <0.01). Table 2 shows the relationship between glycemic status and ASP stratified by sex. Among women, those with a prediabetic glycemic status had a 34% higher estimated risk of ASP (age-adjusted OR: 1.34; 95% CI: 1.11e1.64; p < 0.01), and those with diabetes had a 77% higher estimated risk of ASP compared with controls (age-adjusted OR: 1.77; 95% CI: 1.45e2.18; p < 0.01). A clear linear trend was present for this association among women (p < 0.01). In contrast, there was no association between glycemic status and ASP among men. The age-adjusted OR was 0.91 (p ¼ 0.59) for those with a prediabetic glycemic status and 1.15 (p ¼ 0.44) for those with diabetes compared with controls. Further adjustments for nephropathy, hypertension, smoking, and alcohol consumption did not significantly change the OR estimates. 
Discussion
The definition of ASB is not consistent among different studies. 10, 17 Several studies used urine culture to define ASB, while one study used ASP (pyuria) as an indication of ASB 10 . In the current study, ASP was used as an indication of ASB. Regardless of which criteria were used, misclassification of ASB status is possible. Most studies have shown prevalences of ASB that range from 6% to 10% using urine culture. 9, 16, 17 The prevalence of ASP in 10.6% in the current population is comparable with that of previous studies. The prevalence of ASP among diabetic women was 23.4% in our study, which is also similar to two other studies. Nakano et al reported a prevalence of ASP of 27.9% (pyuria was defined as the presence ofless than 10 leukocytes per high-power field) among diabetic women in Japan, 10 and Geerlings et al 13 documented 26.0% ASB (bacteriuria by urine culture) among 378 diabetic women. Our results suggest that glycemic disorders may increase the risk of ASB in a dose-response manner (p < 0.01), but the effect was limited to women, and was not detected in men (p < 0.01). Although the data are not totally consistent, several reports on Western populations have shown that diabetic women have a higher prevalence of ASB compared with women without the condition. 8, 9, 13, 18 The current study of a Taiwanese population supports the concept that the prevalence of ASB is higher in diabetic women (23.4%) than that in women with a normal glycemic index (13.4%), with an age-adjusted OR of 1.77 (p < 0.01). If diabetes does predispose to ASB, we can speculate that prediabetes also predisposes to ASB. Previous studies have rarely examined whether being prediabetic also increases the risk of ASB. Our data are unique in further showing that even a prediabetic status alone increases the estimated risk of ASB by 34% in women (OR: 1.34, p < 0.01). This doseeresponse relationship greatly augments the plausibility of an association between glycemic disorders and ASB in women. Furthermore, there are few data on whether the proposed association is also true for men. Available data suggest that the prevalence of ASB is not increased in diabetic men versus nondiabetic men. 19, 20 Our data are consistent with previous reports that diabetes does not lead to a higher prevalence of ASB in men. We further showed that a prediabetic status also does not increase the risk of ASB in men.
Age is a well-established risk factor for ASB in diabetic women, while other covariates, such as the duration or control of diabetes, the presence of complications of diabetes including nephropathy and retinopathy, and sexual intercourse, have also been proposed. 13, 21 In our study, the glycemiaeASP association remained unchanged after adjusting for age and nephropathy. Residual confounding is still possible since we have no data on other covariates. We believe that the influence should be limited since age and nephropathy are usually positively associated with the duration of diabetes. In addition, although the distributions of participants who smoked and/or drank alcohol differed between the cases and controls, further adjustment for those factors did not significantly change the OR estimates in this study.
This study has several strengths. First, there were a relatively large number of cases with ASP, yielding a higher power compared with other studies. Second, this was a population-based study with participants recruited from a health checkup program, not diseased populations, thus enhancing the external validity. Third, in contrast to other studies, we explored the association between diabetes and ASB, and that between prediabetes and ASB. The linear trend we found between prediabetes and diabetes with ASB in women strongly supports the theory that glycemic disorders increase the risk of ASB, which in turn may increase the risk of symptomatic UTIs. Fourth, our data showed that glycemic disorders are associated with a higher risk of ASP in women, but not in men. Fifth, in contrast to most other reports, this study provides data from a non-Western population that support the proposed association.
There are also some limitations to our study that deserve discussion. First, we were unable to differentiate between the two primary types of diabetes mellitus: insulin-dependent diabetes mellitus (type I) and non-insulin-dependent diabetes mellitus (type II). The metabolic profiles of the two types may differ, but Geerlings et al showed that women with type I diabetes also have a higher prevalence of ASB compared with normal controls. 13 We believe that this difference between types may have had little effect on our results because the majority of diabetic patients in this study were aged 40 years or older, and therefore most likely to be of type II. Second, we used pyuria defined by urinary leukocyte counts instead of urine culture as a surrogate for bacteriuria. The use of this definition might have led us to observe a less strong association between ASP and diabetes. Third, we assumed that people in this health checkup population were asymptomatic. If that assumption was wrong, the bias might have resulted in a stronger association between ASP and diabetes. Another limitation is that as this was a retrospective study, we were unable to control for some other potential confounding factors pertaining to UTIs, including the presence of anomalies of the urinary tract and the consumption of cranberries, which may have reduced the risk of UTI. Some authors have proposed the following mechanisms to explain why ASB may be more prevalent in people with diabetes, although none have been confirmed. First, the higher glucose concentration in the urine of diabetic patients may serve as a culture medium allowing bacteria to grow faster. 22 Second, those with diabetes may have an impaired host defense system. Diabetic women have lower urinary interleukin-6 concentrations compared with those in normal controls, and interleukin-6 may attenuate host defense mechanisms against systemic and local infections 23, 24 . Tamm-Horsfall protein is a glycoprotein produced in the kidneys and excreted in urine to prevent bacterial attachment to uroepithelial cells by binding type I and S fimbriae of Escherichia coli. 25, 26 Some investigators have proposed that in diabetics, Tamm-Horsfall protein may have a different chemical structure that makes it easier for E. coli to adhere to diabetic uroepithelial cells. 27, 28 Third, there is evidence showing an increased adherence of E. coli to type I fimbriae of uroepithelial cells isolated from diabetic women compared with those from control patients. 29 It has been suggested that diabetic cystopathy and peripheral neuropathy may contribute to the higher risk of UTIs in diabetic patients, but researchers have failed to find a correlation between them. 13, 30 Infecting bacteria in the urine of diabetic people have also not been found to be more virulent than those of nondiabetic individuals. 31 Although a plausible pathogenesis as to why people with diabetes are predisposed to ASB is available as described above, those explanations cannot explain why the effects of glycemic disorders on ASB are only evident in women and not in men.
The clinical implications of ASB can be significant. Ribera et al 6 demonstrated that ASB is a major risk factor for developing symptomatic UTIs. They followed 289 women and 168 men over a 12-month period. Among patients with ASB, 69.2% (67.6% of women and 76.5% of men) developed symptomatic UTIs, while only 9.8% without ASB (14.9% of women and 2.6% of men) developed symptomatic UTIs. 6 Although some investigators disagree about treating asymptomatic UTIs in people with diabetes, 32 we believe prospective randomized trials are necessary to determine whether treating asymptomatic UTIs prevents symptomatic UTIs.
Conclusions
Our results suggest that patients with glycemic disorders have a higher prevalence of ASB, but this is true only for women, not for men. The reason why glycemic disorders are not associated with a higher risk of ASB among men remains unclear. Further research is required to determine how to protect women with diabetes from this diabetic complication.
